- June 2020
- Venture Capital watch: how COVID-19 is affecting and will affect VC transactions with a specific focus on the life sciences and healthcare sectors
- Decreto Rilancio: overview of the main measures to support business and companies in Italy
- May 2020
- Liability for direction and coordination activity
- A new decision from the Court of Milan on simul stabunt simul cadent clauses
- Notes on the ABA 2019 European Private Target M&A Deal Points Study
- April 2020
- The expansion of Italian foreign investment control in the COVID-19 era
- COVID-19 emergency: Italian Government measures to support liquidity through the banking system
- COVID-19: special rules on reduction of corporate capital, business continuity, and extension of the term for approval of financial statements as provided by the Italian Law Decree (Decreto Liquidità)
- Italian Supreme Court confirmed corporate criminal liability of foreign companies pursuant to Legislative Decree No. 231/2001
- Liquidity Decree: the insolvency law measures aimed at ensuring the business continuity
- March 2020
- M&A transactions in the era of the coronavirus health crisis
- Artificial Intelligence can Support Risk Analysis of Contracts and Definition of Mitigating Actions
- Coronavirus emergency and corporate compliance related considerations
- February 2020
- First case of extradition from Italy to United States for price-fixing
- Does corporate purpose limit exercise of the power of representation?
- Resignations of statutory auditors do not exclude their liability
- M&A takeaways to consider after the first heavy sanctions imposed by Italian Data Protection Authority on TIM and Eni
- How “Change of Control” clauses of the equity-holders of a company may be lawful and effective
- When are transfers of quotas of limited liability companies effective?
- December 2019
- W&I Insurance policy: a sophisticated tool for the benefit of both the seller and the buyer